Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bendamustine (treanda) (1 trial)
rituximab (rituxan) (1 trial)
Lymphoma (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Trials (1 total)
Trial APIs (2 total)